Oddity Tech Ltd. (NASDAQ:ODD) is one of the Most Oversold Mid-Cap Stocks to Buy According to Hedge Funds.
On October 8, 2025, KeyBanc Capital Markets analyst Scott Schoenhaus maintained an Overweight rating on Oddity Tech but lowered the price target from $90 to $80.
The firm emphasized that Oddity is still in the early stages of a high-growth story, with upside potential driven by its proprietary hyperspectral + biotech suite and the upcoming Q4 launch of a medical-grade skin and body care brand.
Despite the target cut, KeyBanc remains optimistic about the company’s ability to scale both revenue and margin expansion, noting that revenue growth above 20% and long-term EBITDA margins above 20% remain achievable.
The adjustment appears to depend on a broader compression of multiples for mid-cap growth companies rather than a deterioration in fundamentals. KeyBanc also highlighted that Oddity’s vertically integrated DTC model, combined with its aggressive R&D investments, uniquely positions it in the beauty technology space.
Oddity Tech Ltd. (NASDAQ:ODD) is an AI-powered beauty and wellness platform behind brands like IL MAKIAGE and SpoiledChild. The company integrates machine learning, proprietary data, and biotechnology R&D to personalize consumer products across skin care, cosmetics, and wellness. Oddity went public in 2023 and quickly became one of the most followed players in the digital beauty market.
While we recognize ODD’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 30 stocks that should double in 3 years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None.